Reponsum creates and manages disease-specific, patient knowledge and community building apps in collaboration with pharmaceutical companies. Since entering the market in 2019, the company has launched four platforms, one of them targeting uterine fibroid patients.
The company is now giving its users (any anyone else) the opportunity to invest and has started a crowd-investing campaign on Republic aiming to raise $25K, which was reached within only a few days.
The Responsum Health platform and its services are provided free of charge to all of our users—patients, family members, caregivers, healthcare providers, and medical professionals.
